Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition

计划入组 24 人 · 首次发布于 2011 年 6 月 13 日

Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition

计划入组 28 人 · 首次发布于 2011 年 6 月 13 日

Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed Conditions

计划入组 34 人 · 首次发布于 2010 年 5 月 27 日

Cardiopulmonary agent (Dr Reddy's)

PDE4B inhibitors (Dr Reddy's)

Tocilizumab Biosimilar(Dr. Reddy's Laboratories)

Dr. Reddy's Laboratories Ltd.

India

DR. REDDY'S LABORATORIES, INC.

United States

DR. REDDY'S LABORATORIES LIMITED

Sri Lanka

ImmunoACT Achieves Profitability with India's First CAR-T Therapy, Treating Over 350 Cancer Patients

Dr Reddy's Laboratories to Acquire Dutch Injectable Specialist OctoPlus for €27.39M

Dr Reddy's Secures $370M Licensing Deal for Immutep's Cancer Immunotherapy